Top

Published in:

01-03-2008 | Hepatobiliary-Pancreas

Percutaneous drainage and stenting for palliation of malignant bile duct obstruction

Authors: Otto M. van Delden, Johan S. Laméris

Published in: European Radiology | Issue 3/2008

Abstract

Percutaneous biliary drainage and stenting (PTBD) for palliation of malignant obstructive jaundice has evolved to a safe and effective technique. PTBD is equally effective for treatment of distal and proximal bile obstruction. Metal self-expandable stents have proved superior to plastic stents and should therefore be used. Technical success is >90% en clinical success is >75% in all major series. There are a considerable number of complications, but most can be treated conservatively and procedure-related mortality is <2% in most series. Thirty-day mortality after PTBD is >10% in many series, but this is largely due to the underlying disease. About 10–30% of patients will have recurrent jaundice at some point in their disease after PTBD and require re-intervention.

Yee ACN, Ho CS (1990) Percutaneous biliary drainage: a review. Crit Reve Diagn Imaging 30:247–279

Arner O, Hagsberg S, Seldinger SI (1962) Percutaneous transhepatic cholangiography: puncture of dilated and non dilated bile ducts under roentgen televison control. Surgery 52:561–571

Glenn F, Evans JA, Mujahed Z, Thorbjarnson B (1962) Percutaneous transhepatic cholangiography. Ann Surg 156:451–462PubMedCrossRef

Kaude JV, Weidenmier CH, Agee OF (1969) Decompression of bile ducts with the percutaneous transhepatic technique. Radiology 93:69–71PubMed

Molnar W, Stockum AE (1974) Relief of obstructive jaundice through percutaneous transhepatic catheter. A new therapeutic method. AJR Am J Roentgenol 122:356–367

Ferruci JT Jr, Mueller PR, Harbin WP (1980) Percutaneous transhepatic biliary drainage. Radiology 135:1–13

McPherson GAD, Benjamin JS, Habib NA, Bowley NB, Blumgart LH (1982) Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg 69:261–264PubMedCrossRef

Laméris JS, Obertop H, Jeekel J (1985) Biliary drainage by ultrasound-guided puncture of the left hepatic duct. Clin Radiol 36:269–274PubMedCrossRef

Günther RW, Schild H, Thelen M (1988) Review article: percutaneous transhepatic biliary drainage. Experience with 311 procedures. Cardiovasc Intervent Radiol 11:65–71PubMedCrossRef

10.

Lammer J, Hausegger KA, Fluckiger F, Winkelbauer FW, Wildling R, Klein GE, Thurner SA, Havelec L (1996) Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 201:167–172PubMed

11.

Indar AA, Lobo DN, Gilliam AD, Gregson R, Davidson I, Whittaker S, Doran J, Rowlands BJ, Beckingham IJ (2003) Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 15:915–919PubMedCrossRef

12.

Lee BH, Choe DH, Lee JH, Kim KH, Chin SY (1997) Metallic stents in malignant biliary obstruction: prospective long-term results. AJR Am J Roentgenol 168:741–745PubMed

13.

Bezzi M, Zolovkins A, Cantisani V, Salvatori FM, Rossi M, Fanelli F, Rossi P (2002) New ePTFE/FEP-covered stent in the palliative treatment of malignant biliary obstruction. J Vasc Interv Radiol 13:581–589PubMedCrossRef

14.

Schoder M, Rossi P, Uflacker R, Bezzi M, Stadler A, Funovics MA, Cejna M, Lammer J (2002) Malignant biliary obstruction: treatment with ePTFE-FEP-covered endoprostheses initial technical and clinical experiences in a multicenter trial. Radiology 225:35–42PubMedCrossRef

15.

Hausegger KA, Thurnher S, Bodendorfer G, Zollikofer CL, Uggowitzer M, Kugler C, Lammer J (1998) Treatment of malignant biliary obstruction with polyurethane-covered Wallstents. AJR Am J Roentgenol 170:403–408PubMed

16.

Miyayama S, Matsui O, Akakura Y, Yamamoto T, Nishida H, Yoneda K, Kawai K, Toya D, Tanaka N, Mitsui T, Asada Y (2004) Efficacy of covered metallic stents in the treatment of unresectable malignant biliary obstruction. Cardiovasc Intervent Radiol 27:349–354PubMed

17.

Freeman ML, Overby C (2003) Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc 58:41–49PubMedCrossRef

18.

Lee M, Dawson SL, Mueller PR, Saini S, Lu DS, Goldberg MA, Gazelle GS (1994) Failed metallic biliary stents: causes and management of delayed complications. Clin Radiol 49:857–862PubMedCrossRef

19.

Stoker J, Lameris JS, Nijs HG, Zonderland HM, Terpststra OT, Van Blankenstijn M, Schutte HE (1991) Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 179:703–707PubMed

20.

Stoker J, Lameris JS (1993) Complications of percutaneously inserted biliary Wallstents. J Vasc Interv Radiol 4:767–772PubMed

21.

Stoker J, Lameris JS, Jeekel J (1993) Percutaneously placed Wallstent endoprosthesis in patients with malignant distal biliary obstruction. Br J Surg 80:1185–1187PubMedCrossRef

22.

Becker CD, Glattli A, Maibach R, Baer HU (1993) Percutaneous palliation of malignant obstructive jaundice with the Wallstent endoprosthesis: follow-up and reintervention in patients with hilar and non-hilar obstruction. J Vasc Interv Radiol 4:597–604PubMed

23.

Inal M, Akgul E, Aksungur E, Seydaoglu G (2003) Percutaneous self-expandable uncovered metallic stents in malignant biliary obstruction. Complications, follow-up and reintervention in 154 patients. Acta Radiol 44:139–146PubMedCrossRef

24.

Lee M, Dawson SL, Mueller PR, Krebs TL, Saini S, Hahn PF (1992) Palliation of malignant bile duct obstruction with metallic biliary endoprostheses: technique, results, and complications. J Vasc Interv Radiol 3:665–671PubMedCrossRef

25.

Kaskarelis IS, Papadaki MG, Papageorgiou GN, Limniati MD, Malliaraki NE, Piperopoulos PN (1999) Long-term follow-up in patients with malignant biliary obstruction after percutaneous placement of uncovered wallstent endoprostheses. Acta Radiol 40:528–533PubMedCrossRef

26.

Oikarinen H, Leinonen S, Karttunen A, Tikkakoski T, Hetemaa T, Makela J, Paivasanalo M (1999) Patency and complications of percutaneously inserted metallic stents in malignant biliary obstruction. J Vasc Interv Radiol 10:1387–1393PubMedCrossRef

27.

Hamy A, d’Allincort A, Paineau J, Lerat F, Gibaud H, Lebogne J, Visset J (1997) Percutaneous self-expandable metallic stents and malignant biliary strictures. Eur J Surg Oncol 23:403–408PubMedCrossRef

28.

Roeren T, Tonn W, Richter GM, Brambs HJ, Kauffmann G (1996) Percutaneous therapy of malignant obstructive jaundice using expandable metal stents: a prospective study of 92 patients. Rofo 165:181–187PubMed

29.

Rossi P, Bezzi M, Rossi M, Adam A, Chetty N, Roddie ME, Iacari V, Cwikiel W, Zollikofer CL, Antonucci F (1994) Metallic stents in malignant biliary obstruction: results of a multicenter European study of 240 patients. J Vasc Interv Radiol 5:279–285PubMed

30.

Inal M, Akgul E, Aksungur E, Demiryurek H, Yagmur O (2003) Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 14:1409–1416PubMed

31.

Lee DH, Yu JS, Hwang JC, Kim KH (2000) Percutaneous placement of self-expandable metallic biliary stents in malignant extrahepatic strictures: indications of transpapillary and suprapapillary methods. Korean J Radiol 1:65–72PubMedCrossRef

32.

Hatzidakis AA, Tsetis D, Chrysou E, Sanidas E, Petrakis E, Gourtsoyiannis NC (2001) Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case? Cardiovasc Intervent Radiol 24:245–248PubMedCrossRef

33.

Stoker J, Lameris JS, Van Blankenstijn M (1993) Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction. Gastrointest Endosc 39:43–49PubMed

34.

Schima W, Prokesch R, Osterreicher C, Thurnher S, Fugger R, Schofl R, Havelec L, Lammer J (1997) Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction. Clin Radiol 52:213–219PubMedCrossRef

35.

Dinkel HP, Triller J (2001) Primary and long-term success of percutaneous biliary metallic endoprotheses (Wallstents) in malignant obstructive jaundice. Rofo 173:1072–1078PubMed

36.

Lillemoe KD, Sauter PK, Pitt HA, Yeo CJ, Cameron JL (1993) Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet 176:1–10PubMed

37.

Van Wagensveld, Coene PP, Van Gulik TM, Rauws EA, Obertop H, Gouma DJ (1997) Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg 84:1402–1406PubMedCrossRef

38.

Lesurtel M, Dehni N, Tiret E, Parc R, Paye F (2006) Palliative surgery for unresectable pancreatic and periampullary cancer: a reappraisal. J Gastrointest Surg 10:286–291PubMedCrossRef

39.

Smith AC, Dowsett JF, Russell RCG, Hatfield ARW, Cotton PB (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344:1655–1660PubMedCrossRef

40.

Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P (1989) Randomised trial of endoscopic endoprothesis versus operative bypass in malignant obstructive jaundice. Gut 30:1132–1135PubMedCrossRef

41.

Hyoty MK, Nordback IH (1990) Biliary stent or surgical bypass in unresectable pancreatic cancer with obstructive jaundice. Acta Chir Scand 156:391–396PubMed

42.

Shepherd HA, Royle HA, Ross APR, Diba A, Arthur M, Colin-Jones D (1988) Endoscopic biliary endoprothesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 75:1166–1168PubMedCrossRef

43.

Bornman PC, Harries-Jones EP, Tobias R, Van Stiegmann G, Terblanche J (1986) Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1:69–71PubMedCrossRef

44.

Raikar GV, Melin MM, Ress A, Lettieri SZ, Poterucha JJ, Nagorney DM, Donohue JH (1996) Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncol 3:470–475PubMedCrossRef

45.

Taylor MC, McLeod RS, Langer B (2000) Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis. Liver Transpl 6:302–308PubMedCrossRef

46.

Van den Bosch RP, Van der Schelling GP, Klinkenbijl JH, Mulder PG, Vab Blankenstein M, Jeekel J (1994) Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg 219:18–24PubMedCrossRef

47.

Moss AC, Morris E, Mac Mathuna P (2006) Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev (2):CD004200

48.

Kaw M, Singh S, Gagneja H, Azad P (2003) Role of self-expandable metal stents in the palliation of malignant duodenal obstruction. Surg Endosc 17:646–650PubMedCrossRef

49.

Singal D, Van Gulik TM, Gouma DJ (2005) Palliative management of hilar cholangiocarcinoma. Surg Oncol 14:59–74CrossRef

50.

Rumalla A, Baron TH (1999) Evaluation and endoscopic palliation of cholangiocarcinoma. Management of cholangiocarcinoma. Dig Dis 17:194–200PubMedCrossRef

51.

Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24:189–199PubMedCrossRef

52.

Speer AG, Cotton PB, Russel RC, Mason RR, Hatfield AR, Leung JW, Mac Rae KD, Houghton J, Lennon CA (1987) Randomized trial of endoscopic versus percutaneous stent instertion in malignant obstructive jaundice. Lancet 2(8550):57–62PubMedCrossRef

53.

Pinol V, Castelis A, Bordas JM, Real MI, Llach J, Montana X, Feu F, Navarro S (2002) Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 225:27–34PubMedCrossRef

54.

Naggar E, Krag E, Matzen P (1990) Endoscopically inserted biliary endoprostesis in malignant obstructive jaundice. A survey of the literature. Liver 10:321–324PubMed

55.

Dowsett JF, Williams SJ, Hatfield ARW, Vaira D, Ainley C, Polydorou AA, Cotton PB, Russell RCG (1989) Endoscopic management of low biliary obstruction due to irresectable primary pancreato-biliary malignancy. A review of 463 consecutive cases. Gastroenterology 96:A129

56.

Kaufman SL (1995) Percutaneous palliation of unresectable pancreatic cancer. Surg Clin North Am 75:989–999PubMed

57.

Davids PH, Groen AK, Rauws EA, Tygtat GN, Huibregste K (1992) Randomized trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488–1492PubMedCrossRef

58.

Wagner HJ, Knyrim K, Vakil N, Klose KJ (1993) Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction. Endoscopy 25:213–218PubMed

59.

Harewood GC, Baron TH, LeRoy AJ, Petersen BT (2002) Cost-effectiveness analysis of alternative strategies for palliation of distal biliary obstruction after a failed cannulation attempt. Am J Gastroenterol 97:1701–1707PubMedCrossRef

60.

Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB (1999) Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc 49:466–471PubMedCrossRef

61.

Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tytgay GH, Huibregtse K (2002) Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 56:33–39PubMedCrossRef

62.

Ducreux M, Liguory C, Lefebvre JF, Ink O, Choury A (1992) Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 37:778–783PubMedCrossRef

Title: Percutaneous drainage and stenting for palliation of malignant bile duct obstruction
Authors: Otto M. van Delden
Johan S. Laméris
Publication date: 01-03-2008
Publisher: Springer-Verlag
Published in: European Radiology / Issue 3/2008
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-007-0796-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Percutaneous drainage and stenting for palliation of malignant bile duct obstruction

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

The rate of incidental findings in lung cancer screening trials is not negligible

Diagnostic imaging of gout: comparison of high-resolution US versus conventional X-ray

Multiple biliary hamartomas: magnetic resonance features with histopathologic correlation

Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

Radiation dose estimates in dual-source computed tomography coronary angiography